Results 51 to 60 of about 414 (161)

[The role of calcium sensitive and vitamin D receptors in the pathogenesis of sporadic multiple parathyroid gland disease]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Ilyicheva EA   +4 more
europepmc   +1 more source

[The clinical practice guidelines for primary hyperparathyroidism, short version]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2021
Mokrysheva NG   +22 more
europepmc   +1 more source

[Quality of life in patients with primary hyperparathyroidism before and at different time-points after surgery and factors associated with its improvement]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Ionova TI   +11 more
europepmc   +1 more source

THE UTILITARIAN PRAGMATISM OF THE CONCEPTS OF KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES AND CHRONIC KIDNEY DISEASE ON THE SIDELINES OF THE PARADIGMS OF BIOLOGY AND PHYSIOLOGY

open access: yesМедицина в Кузбассе
The publication claims that the 20-year stagnation of the clinical settings of the concepts of Kidney Disease Improving Global Outcomes (KDIGO) and Chronic Kidney Disease (CKD), their operation with distorted beliefs about renal processes and functions ...
Владимир Валентинович Разумов
doaj  

[Quality of life in patients with primary hyperparathyroidism after surgery]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2022
Nikitina TP   +6 more
europepmc   +1 more source

[The impact of carbohydrate metabolism disorders on the early and long-term clinical outcomes of patients with COVID-19 according to the AKTIV and AKTIV 2 registries]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Salukhov VV   +8 more
europepmc   +1 more source

Итоговое резюме KDIGO 2018 по гепатиту С для рекомендаций по ХБП: достижения в оценке и менеджменте

open access: diamond, 2018
Michel Jadoul   +17 more
openalex   +2 more sources

ЛЕЧЕНИЕ ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ БОЛЕЗНЬЮ ПОЧЕК 5 СТАДИИ (ХБП 5) МЕТОДАМИ ГЕМОДИАЛИЗА И ГЕМОДИАФИЛЬТРАЦИИ. КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ

open access: yes, 2017
А. Г. Строков   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy